Cannabis and Older Adults: Risks Seniors Should Know
Populations
2x Since 2015
Adults over 65 are the fastest growing group of cannabis users with usage rates that roughly doubled between 2015 and 2019, and aging bodies hold THC longer due to increased fat and slower metabolism.
Han & Palamar, Drugs and Aging, 2018
Han & Palamar, Drugs and Aging, 2018
View as imageIf you are over 60 and considering cannabis for pain, sleep, or anxiety, you are not alone. Seniors and older adults represent the fastest growing group of cannabis users in the country. But the risks of cannabis look different after 60 than they do at 30. Your body processes THC differently. Your medication list is likely longer. Your balance and cognitive reserves are already changing. And most cannabis research was conducted on younger populations, which means the safety data that exists may not fully apply to you. Understanding these age-specific risks and medication interactions is not about fear. It is about making informed decisions with a clear picture of how cannabis interacts with an aging body. While cannabis does have proven medical benefits for certain conditions, the risk profile shifts significantly after 60 in ways that require careful consideration.
Key Takeaways
- Adults over 65 are the fastest growing group of cannabis users in the U.S. — usage rates roughly doubled between 2015 and 2019 according to the National Survey on Drug Use and Health
- As you age, your body holds more fat and less water, so THC gets stored longer and cleared more slowly — which means the same dose hits harder and lasts longer in an older body
- Cannabis can interfere with common medications like blood thinners (warfarin), blood pressure drugs, sedatives, and SSRIs because it affects the same liver enzymes in the CYP450 system that process those drugs
- THC throws off your balance and slows reaction time, which stacks on top of the fall risk that already climbs with age — and falls are the leading cause of injury-related death in adults over 65
- The memory and focus effects of regular cannabis use can look a lot like normal aging, making it harder to spot early cognitive decline — and may actually make it worse
- A 2021 study in the Journal of the American Geriatrics Society found that older adults who used cannabis fell significantly more often than non-users, with inhaled cannabis posing the greatest risk because of rapid-onset dizziness
Why Cannabis Affects Older Adults Differently
Why Cannabis Hits Different After 60: Age-Related Risk Factors
THC stored longer, released slowly — same dose hits harder and lasts longer
THC and 11-hydroxy-THC processed more slowly — longer intoxication window
THC metabolites take longer to eliminate — effects build up
Elevated INR → dangerous bleeding
Excessive BP drops → dizziness, falls
Amplified sedation → fall risk
Increased opioid levels → respiratory depression
Fall risk compounds: THC impairs balance + cannabis causes orthostatic hypotension + BP meds amplify dizziness + age-related muscle loss and neuropathy. Hip fractures in adults over 65 carry a 20–30% one-year mortality rate.
The way your body handles THC changes as you age, and these changes consistently push in the same direction: toward stronger and longer-lasting effects from the same dose.
Body composition shifts. As you age, you carry proportionally more fat and less water. THC is fat-soluble (it dissolves in fat rather than water), which means it gets stored in fat tissue and released slowly. In an older body with more fat tissue, THC accumulates more and takes longer to clear. A 2019 review in Drugs and Aging noted that these pharmacokinetic changes mean older adults experience more pronounced and prolonged effects from the same dose a younger person handles easily.
Liver metabolism slows. Your liver breaks down THC into its metabolites (the byproducts your body eventually eliminates). Liver function declines with age and blood flow to the liver decreases. THC and its active metabolite, 11-hydroxy-THC (the compound that makes edibles feel stronger than smoking), are processed more slowly. The result is a longer window of intoxication from a given dose.
Kidney clearance decreases. Your kidneys eliminate THC metabolites from your body. Kidney function declines by roughly 1% per year after age 40. Slower clearance means THC byproducts stay in your system longer, extending both desired and unwanted effects.
Medication Interactions That Matter Most for Seniors
The average adult over 65 takes four or more prescription medications. Cannabis, particularly through its effects on the cytochrome P450 enzyme system (CYP450, the family of liver enzymes that metabolizes most drugs), can interfere with how many of those medications work. For a detailed breakdown of how cannabis affects these liver enzymes, see the full guide on medication interactions when quitting weed.
Blood Thinners
Warfarin is one of the most commonly prescribed blood thinners in older adults, and it is metabolized through CYP2C19 and CYP3A4, two enzymes that cannabis inhibits. This can raise the effective level of warfarin in your blood, increasing the risk of dangerous bleeding. A 2018 case series published in the Journal of the American Pharmacists Association documented several cases of significantly elevated INR levels (the measure of clotting time) in patients who started using cannabis while on warfarin. If you take any blood thinner, cannabis use is a conversation that must involve your prescriber.
Blood Pressure Medications
Many older adults take calcium channel blockers (like amlodipine) or beta blockers for blood pressure management. These medications rely on CYP3A4 for metabolism. Cannabis inhibiting this enzyme can cause blood pressure medications to accumulate at higher-than-intended levels, potentially leading to blood pressure drops that cause dizziness or fainting. At the same time, cannabis itself can cause orthostatic hypotension (a sudden drop in blood pressure when you stand up), creating a compounding effect. For more on how cannabis affects your cardiovascular system, see the cannabis cardiovascular risk overview.
Sedatives and Sleep Medications
Benzodiazepines like alprazolam (Xanax) and diazepam (Valium), as well as sleep aids like zolpidem (Ambien), are metabolized through CYP3A4. Adding cannabis to these medications can amplify sedation, impair coordination more than either substance alone, and increase fall risk. Research published in Clinical Pharmacology and Therapeutics has shown that dual sedation from cannabinoids and benzodiazepines can produce effects greater than what you would expect from adding the two together.
Pain Medications
Opioids prescribed for chronic pain are often metabolized through CYP3A4. Cannabis can increase opioid blood levels by slowing their metabolism, raising the risk of excessive sedation and respiratory depression. Even if you are using cannabis to reduce opioid use, the interaction needs medical management. The evidence on cannabis for chronic pain is discussed in the cannabis and chronic pain research guide.
Fall Risk: A Serious and Underestimated Danger
Falls are the leading cause of injury-related death in adults over 65, according to the Centers for Disease Control and Prevention (CDC). Cannabis directly increases fall risk through several mechanisms that overlap with existing age-related vulnerabilities.
THC impairs balance, coordination, and reaction time. These effects are well documented in younger populations, but they take on greater significance in an older body where balance is already compromised by muscle loss, joint stiffness, reduced proprioception (your body's sense of where it is in space), and possible neuropathy (nerve damage in the feet that reduces sensation).
A 2021 study published in the Journal of the American Geriatrics Society found that older adults who used cannabis had a significantly higher rate of falls compared to non-users. The risk was particularly elevated with inhaled cannabis, which produces rapid-onset effects that can catch you off guard.
The combination of cannabis-induced dizziness, orthostatic hypotension from both cannabis and blood pressure medications, and age-related balance deficits creates a scenario where a single misstep can result in a hip fracture, head injury, or worse. Hip fractures in adults over 65 carry a one-year mortality rate of roughly 20 to 30%.
Cognitive Effects Compound with Age-Related Decline
Regular cannabis use affects memory, attention, and processing speed. In younger adults, these cognitive effects are generally reversible after a period of abstinence. The picture is less clear in older adults, where age-related cognitive decline is already underway.
A 2020 review in Ageing Research Reviews noted that the endocannabinoid system (the body's own system of cannabinoid receptors and signaling molecules) changes with age, with CB1 receptor density declining in brain regions involved in memory. Introducing external cannabinoids like THC into this already-shifting system may accelerate or complicate normal cognitive aging.
The concern is also that cognitive impairment from cannabis use can be mistaken for, or mask, the early signs of dementia. If you are experiencing memory problems and attributing them to aging, regular cannabis use may be a contributing factor worth evaluating. For more on how the brain's cannabinoid system recovers, see the guide on cannabinoid receptor recovery time.
Cannabis Withdrawal in Older Adults
If you have been using cannabis regularly and decide to stop, withdrawal symptoms are a real possibility regardless of your age. The complete guide to cannabis withdrawal covers the full timeline and symptom picture. But there are a few age-specific considerations worth noting.
Sleep disruption during withdrawal can be particularly challenging for older adults who already struggle with insomnia. Cannabis withdrawal commonly causes difficulty falling asleep, vivid dreams, and reduced sleep quality for two to six weeks. If you were using cannabis specifically to manage sleep problems, stopping may temporarily make those problems worse before they improve.
Irritability and anxiety during withdrawal can also be amplified in older adults who are managing other health stressors, social isolation, or grief. These emotional symptoms are temporary, typically peaking in the first one to two weeks, but they can feel more destabilizing when layered on top of other life challenges.
The medication interactions described earlier also shift during withdrawal. As cannabis leaves your system and your liver enzymes return to their baseline activity, medications that were being processed more slowly may now clear faster. This means your existing doses may become less effective during the withdrawal period. Coordinating your quit plan with your prescriber is essential.
Practical Considerations for Older Adults
If you are currently using cannabis or considering it, several strategies can reduce risk.
Talk to your doctor honestly about your cannabis use. Many older adults hesitate because of generational stigma, but your prescriber needs this information to manage your medications safely.
Start with the lowest possible dose if you are new or returning to cannabis after decades. THC potency has roughly tripled since the mid-1990s, and your body processes it differently now.
Avoid inhaled cannabis if fall risk is a concern. Inhaled cannabis produces rapid-onset dizziness that peaks within minutes. Edibles allow a slower onset but require careful dosing because the delayed effects (30 to 90 minutes) can lead to overconsumption.
Understand the difference between CBD and THC. CBD does not produce intoxication, though it still affects liver enzymes and can interact with medications.
When to Seek Professional Help
If you are experiencing falls, confusion, unusual bleeding, significant blood pressure changes, or any sudden worsening of symptoms that may be connected to cannabis use or to stopping cannabis, contact your healthcare provider promptly.
If you are finding it difficult to reduce or stop cannabis use despite wanting to, that is worth discussing with your doctor. Cannabis use disorder is a recognized medical condition, and effective treatments exist.
SAMHSA's National Helpline is available at 1-800-662-4357. It is free, confidential, and open 24 hours a day, 7 days a week. You can also text "HELLO" to 741741 to reach the Crisis Text Line.
Making Informed Choices at Any Age
The rise in cannabis use among older adults reflects a genuine search for relief from pain, insomnia, and anxiety, conditions that become more common and harder to manage with age. That search is reasonable. But the pharmacology of aging means that cannabis carries risks for a 70-year-old that it simply does not carry for a 25-year-old. Slower metabolism, more medications, greater fall risk, and changing brain chemistry all shift the equation. Knowing these differences does not make the decision for you. It gives you the information to make the decision yourself, with your eyes open and your doctor in the loop.
The Bottom Line
Adults over 65 are the fastest-growing cannabis demographic (usage roughly doubled 2015-2019 per NSDUH). Age-specific pharmacokinetic changes all push toward stronger, longer effects from the same dose: more body fat (THC stored longer as it is lipophilic), slower liver metabolism (reduced CYP450 enzyme activity, slower 11-hydroxy-THC clearance per 2019 Drugs and Aging review), and declining kidney function (~1% per year after 40, slower metabolite elimination). Medication interactions through CYP450 system are the highest-risk concern: warfarin (CYP2C19/CYP3A4 inhibition → elevated INR → bleeding risk, 2018 Journal of the American Pharmacists Association case series), blood pressure drugs (calcium channel blockers/beta blockers via CYP3A4 → accumulation → hypotension/dizziness), sedatives (benzodiazepines/zolpidem via CYP3A4 → amplified sedation → fall risk), opioids (CYP3A4 → increased blood levels → respiratory depression risk). Fall risk: leading cause of injury death in 65+, cannabis impairs balance/coordination/reaction time compounding age-related deficits (2021 Journal of the American Geriatrics Society — significantly higher fall rates among older cannabis users), hip fracture 1-year mortality 20-30%. Cognitive concerns: CB1 receptor density already declining with age (2020 Ageing Research Reviews), cannabis may accelerate cognitive aging or mask early dementia signs. Age-specific withdrawal considerations: sleep disruption more challenging, emotional symptoms amplified by isolation/grief, medication dose effectiveness may shift as liver enzymes return to baseline. Practical guidance: honest doctor conversation, lowest possible dose, avoid inhalation for fall risk, understand CBD vs THC interactions.
Frequently Asked Questions
Sources & References
- 1RTHC-08512·Murri, Martino Belvederi et al. (2026). “Large meta-analysis finds regular cannabis use raises both pro-inflammatory and anti-inflammatory markers, not just one or the other.” Brain.Study breakdown →PubMed →↩
- 2RTHC-08708·Weidberg, Sara et al. (2026). “Nearly 29% of North Americans have tried CBD, about double the rate in Europe.” Addiction (Abingdon.Study breakdown →PubMed →↩
- 3RTHC-06153·Candeloro, Bruno Moreira et al. (2025). “Meta-Analysis Found CBD and THC Had Trivial Effects on Blood Inflammation Markers.” International journal of molecular sciences.Study breakdown →PubMed →↩
- 4RTHC-06220·Chou, Roger et al. (2025). “Cannabis products with THC showed small pain improvements with significant side effects, while CBD alone did not help.” Pain and therapy.Study breakdown →PubMed →↩
- 5RTHC-05271·Ding, Cheng et al. (2024). “Meta-analysis found cannabis use disorder linked to more complications and higher costs after hip and knee replacements.” The Journal of the American Academy of Orthopaedic Surgeons.Study breakdown →PubMed →↩
- 6RTHC-03713·Bilbao, Ainhoa et al. (2022). “Major meta-analysis of 152 RCTs finds cannabinoid effectiveness varies dramatically by specific drug and condition.” BMC medicine.Study breakdown →PubMed →↩
- 7RTHC-04223·Silvinato, Antônio et al. (2022). “Meta-analysis confirmed CBD reduces seizures by 33% in treatment-resistant epilepsy.” Revista da Associacao Medica Brasileira (1992).Study breakdown →PubMed →↩
- 8RTHC-03179·Gunning, Boudewijn et al. (2021). “CBD reduced seizures in both Dravet and Lennox-Gastaut syndromes, with enhanced effects when combined with clobazam.” Acta neurologica Scandinavica.Study breakdown →PubMed →↩
Research Behind This Article
Showing the 8 most relevant studies from our research database.
Regular cannabinoid use and inflammatory biomarkers: Systematic review and hierarchical meta-analysis.
Murri, Martino Belvederi · 2026
Cannabis use was associated with higher anti-inflammatory biomarkers (SMD = 0.298, PD = 99%) and pro-inflammatory biomarkers (SMD = 0.166, PD = 100%).
The prevalence of cannabidiol (CBD) use in North America and Europe: A meta-analysis.
Weidberg, Sara · 2026
CBD use was significantly more prevalent in North America than Europe across all time periods.
The Pleiotropic Influence of Cannabidiol and Tetrahydrocannabinol on Inflammatory Biomarkers: A Systematic Review and Meta-Analytical Synthesis.
Candeloro, Bruno Moreira · 2025
Pooled estimates showed trivial and imprecise effects: IL-6 (SMD -0.17, p=0.41), IL-8 (SMD -0.30, p=0.06), IL-10 (SMD -0.10, p=0.79), and TNF-alpha (SMD -0.09, p=0.62).
Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks.
Chou, Roger · 2025
THC:CBD oral spray: small pain decrease (MD -0.54/10); high THC: small decrease (MD -0.78/10); CBD alone: no benefit (moderate SOE); THC products caused large dizziness increase (RR 3.57) and sedation increase (RR 5.04)..
Cannabis Use Disorder Associated With Increased Risk of Postoperative Complications After Hip or Knee Arthroplasties: A Meta-analysis of Observational Studies.
Ding, Cheng · 2024
Across 10 studies with 17,981,628 participants, CUD was associated with significantly higher odds of medical complications (OR 1.33), implant-related complications (OR 1.75), cardiac complications (OR 1.95), stroke (OR 2.06), infections (OR 1.68), periprosthetic fracture (OR 1.42), mechanical loosening (OR 1.54), and dislocation (OR 1.88).
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
Bilbao, Ainhoa · 2022
CBD showed high-grade evidence for epilepsy (SMD -0.5) and moderate-grade for Parkinsonism (SMD -0.41).
Use of cannabidiol in the treatment of epilepsy: Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.
Silvinato, Antônio · 2022
CBD compared to placebo reduced seizure frequency by 33%, increased 50% seizure reduction by 20%, increased seizure freedom by 3%, and improved caregiver-assessed clinical impression by 21% in patients with refractory epilepsy..
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.
Gunning, Boudewijn · 2021
CBD reduced primary seizure frequency versus placebo in LGS (treatment ratio 0.70) and Dravet syndrome (0.71) in the overall population.